Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Ideas
Benchmark
Sign in
Sign up
H
HKPD.HK
Cellyan Biotechnology Ltd.
Healthcare
Medical - Pharmaceuticals
HK
Healthcare · Medical - Pharmaceuticals · HK
Also listed · HKPD →
—
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Ideas
Oct 21, 2026, 12:00 UTC
Cellyan Biotechnology announced a 1-for-20 reverse stock split of its Class A and Class B ordinary shares, effective at the market opening on October 26, 2026.
Source:
globenewswire.com